Farther Finance Advisors, LLC

Position in HIMS — Hims & Hers Health, Inc.

CIK 1992825 SAN FRANCISCO, CA

Position in HIMS

as of Jun 30, 2026 · filed Jul 17, 2026 Compact

Position Value

$707,961

+$275,634 QoQ

Shares Held

20,420

-1.9% QoQ

Ownership

0.009%

of shares outstanding

% of Portfolio

0.02%

of 13F equity value

Holder Rank

#242

of 504 holders

Holding Since

Dec 2023

11 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

Farther Finance Advisors, LLC holds $5,620,756 across 55 Drug Manufacturers - Specialty & Generic names. HIMS ranks #2 (12.6% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	UTHR	UNITED THERAPEUTICS Corp	1,312	$710,880
2	HIMS	Hims & Hers Health, Inc. This page	20,420	$707,961
3	ZTS	Zoetis Inc.	8,686	$624,175
4	VTRS	Viatris Inc	39,209	$622,638
5	TEVA	Teva Pharmaceutical Industries Ltd	14,418	$488,481
6	COLL	Collegium Pharmaceutical, Inc	13,324	$482,328
7	NBIX	Neurocrine Biosciences Inc	2,503	$421,855
8	TAK	Takeda Pharmaceutical Co Ltd	21,332	$341,951

11 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$707,961	20,420	-1.9%	Shares	Sole	2026-07-17
2026-03-31	$432,327	20,825	+3.8%	Shares	Sole	2026-04-07
2025-12-31	$651,250	20,057	+5.5%	Shares	Sole	2026-01-23
2025-09-30	$1,077,963	19,005	+121.4%	Shares	Sole	2025-10-14
2025-06-30	$427,912	8,584	+5.7%	Shares	Sole	2025-07-11
2025-03-31	$240,005	8,122	+12.9%	Shares	Sole	2025-04-14
2024-12-31	$173,902	7,192	+1.0%	Shares	Sole	2025-02-10
2024-09-30	$131,150	7,120	+0.6%	Shares	Sole	2024-10-29
2024-06-30	$142,844	7,075	0.0%	Shares	Sole	2024-07-31
2024-03-31	$109,450	7,075	+9333.3%	Shares	Sole	2024-05-14
2023-12-31	$667	75	—	Shares	Sole	2024-02-15
No filing history on record for this holder in this stock.